缓解长期COVID患者的疲劳 MYP:一个临床观察
Yu-Jin Choi1,2, Jin-Seok Lee1,2, Jin-Yong Joung1,2
1Research Center for CFS/ME, Daejeon University Hospital, Daedukdae-ro 176 bun-gil 75, Seo-gu, Daejeon, 35235, Republic of Korea.
BMC infectious diseases
|April 26, 2025
概括
这项研究探讨了MYPplus,一种草药配方,用于长期COVID症状. MYPplus显著改善了疲劳和脑雾,提高了患者的生活质量.
科学领域:
- 草药是一种草药.
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
背景情况:
- 长期COVID是一种次要的公共卫生危机,影响了大约10%的COVID-19幸存者.
- 疲劳和脑雾是普遍存在的,使人衰弱的长期COVID症状,目前没有标准化的治疗方法.
- 这项研究调查了 MYPplus 的疗效,一种草药配方,用于管理这些症状.
研究的目的:
- 评估MYPplus在缓解长期COVID患者疲劳和脑雾方面的疗效.
- 评估MYPplus对整体生活质量的影响.
- 为了探索MYPplus的潜在免疫调节作用.
主要方法:
- 一项涉及50名长期COVID患者的观察性研究.
- 参与者接受了MYPplus (500毫克囊,每天两次两次囊,持续4周).
- 症状评估包括mKCFQ11,MFI-20,疲劳VAS,大脑雾VAS,SF-12和细胞因子/皮质醇水平.
主要成果:
- 在疲劳 (mKCFQ11,MFI-20,疲劳VAS) 和脑雾 (脑雾VAS) (p <0.01) 中观察到显著改善.
- 通过SF-12测量的生活质量增加了59% (p < 0.01).
- 血TGF-β水平呈现下降趋势 (p = 0.07),没有观察到安全问题.
结论:
- MYPplus显示了管理长期COVID疲劳相关症状和改善生活质量的潜力.
- 需要进一步进行大规模随机化安慰剂对照试验,以确认疗效和安全性.
- 这项试点研究强调MYPplus是长期COVID管理的有希望的治疗选择.
相关概念视频
Muscle Recovery and Fatigue
1.8K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
1.8K
Myasthenia Gravis: Overview and Treatment
943
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
943
Pneumonia V: Nursing management and Prevention
1.6K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.6K
Myasthenia Gravis: Diagnostic Tests
531
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
531
Cystic Fibrosis: Management
94
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
94


